Therapeutics for Neurodegenerative Diseases

Coming soon…

Featured publications

Mattsson-Carlgren N, Grinberg LT, Boxer A, Ossenkoppele R, Jonsson M, Seeley W, Ehrenberg AJ, Spina S, Janelidze S, Rojas-Martinez J, Rosen H, La Joie R, Lesman-Segev O, Iaccarino L, Kollmorgen G, Ljubenkov P, Eichenlaub U, Gorno-Tempini ML, Miller B, Hansson O, and Rabinovici GD. Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration. Neurology. 98(11): e1137-e1150. 2022. PMID: 35173015. PubMed

Ehrenberg AJ, Khatun A, Coomans E, Betts M, Capraro F, Thijssen E, Senkevich K, Bharucha T, Schott JM, Pereira J, Mattsson N, Grinberg LT, Jagust W, Lashley T, Carter SF, Ashton N, Hanrieder J, Zetterberg H, Schöll M, Paterson RW. Relevance of Biomarkers Across Different Neurodegenerative Diseases. Alzheimer’s Research and Therapy. 12(56). 2020. PMID: 32404143. PubMed

Betts MJ, Kirilina E, Otaduy MCG, Ivanov D, Acosta-Cabronero J, Callaghan MF, Lambert C, Cardenas-Blanco A, Pine K, Passamonti L, Loane C, Keuken MC, Trujillo P, Lüsebrink F, Mattern H, Liu KY, Priovoulos N, Fliessbach K, Dahl MJ, Maaß A, Madelung CF, Meder D, Ehrenberg AJ, Speck O, Weiskopf N, Dolan R, Inglis B, Tosun D, Morawski M, Zucca FA, Siebner HR, Mather M, Uludag K, Heinsen H, Poser BA, Howard R, Zecca L, Rowe JB, Grinberg LT, Jacobs HIL, Düzel E, Hämmerer D. Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. Brain. 142(9): 2558–2571. 2019. PMID: 31327002. PubMed